Pharvaris NV (PHVS)
22.90
-1.08
(-4.50%)
USD |
NASDAQ |
Nov 05, 16:00
22.90
0.00 (0.00%)
After-Hours: 20:00
Pharvaris Total Assets (Quarterly): 377.14M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 377.14M |
| March 31, 2024 | 407.77M |
| December 31, 2023 | 440.72M |
| September 30, 2023 | 179.25M |
| June 30, 2023 | 206.20M |
| March 31, 2023 | 161.17M |
| December 31, 2022 | 179.88M |
| September 30, 2022 | 199.51M |
| June 30, 2022 | 215.96M |
| Date | Value |
|---|---|
| March 31, 2022 | 224.49M |
| December 31, 2021 | 240.13M |
| September 30, 2021 | 258.76M |
| June 30, 2021 | 273.38M |
| March 31, 2021 | 286.07M |
| December 31, 2020 | 124.35M |
| September 30, 2020 | 50.55M |
| December 31, 2019 | 23.07M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
23.07M
Minimum
Dec 2019
440.72M
Maximum
Dec 2023
226.38M
Average
215.96M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| uniQure NV | 730.85M |
| ProQR Therapeutics NV | 126.54M |
| Merus NV | 844.68M |
| argenx SE | -- |
| Pharming Group | 425.51M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.45M |
| Shareholders Equity (Quarterly) | 356.69M |